Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10759774
Inhibitors of hepatitis B virus targeting capsid assembly
granted -
US 10758619
Controlled release mucoadhesive systems
granted -
US 10758598
TPP-1 formulations and methods for treating CLN2 disease
granted -
US 10759863
Modulation of γδ T cells
granted -
US 10758534
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 10758496
Estrogen receptor ligand treatment for neurodegenerative diseases
granted -
US 10759768
Prophylactic or therapeutic agent for autism spectrum disorder
granted -
US 10758513
Modulators of mitochondrial protein import
granted -
US 10758600
Fungal immunogens and related materials and methods
granted -
US 10758617
Pharmaceutical compositions comprising meloxicam
granted -
US 10758613
Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells
granted -
US 10758614
Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase
granted -
US 10759721
Deuterated CFTR potentiators
granted -
US 10758621
Liquid formulation comprising GM-CSF neutralizing compound
granted -
US 10758642
Sterilization process
granted -
US 10759759
Prodrugs of kallikrein inhibitors
granted -
US 10758629
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 10758632
NIR-conjugated tumor-specific antibodies and uses thereof
granted -
US 10759795
Aza-A-ring indenoisoquinoline topoisomerase I poisons
granted -
US 10759791
Mammalian and bacterial nitric oxide synthase inhibitors
granted -
US 10759808
Monofunctional intermediates for ligand-dependent target protein degradation
granted -
US 10759796
CXCR4 inhibitors and uses thereof
granted -
US 10759812
Thienopyrimidine derivative and use thereof in medicine
granted -
US 10759838
Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.